About AIM
AIM is a company based in Voorburg (Netherlands) founded in 2009 was acquired by Blue Matter Consulting in January 2021. It operates as a Professional Services. AIM offers products and services including Supply Chain Development, Consulting, Maintenance Support, and Interim Professionals. AIM operates in a competitive market with competitors including McKesson, Resilience, Entero Healthcare, BioAscent and Zhejiang Mingdu Zhikong Technology, among others.
- Headquarter Voorburg, Netherlands
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Blue Matter Consulting
(Jan 18, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AIM
AIM offers a comprehensive portfolio of products and services, including Supply Chain Development, Consulting, Maintenance Support, and Interim Professionals.
Supply chain strategy is designed for life science startups.
Strategic consulting is provided for supply chain challenges.
Ongoing management is offered for supply chain functions.
Experienced professionals are provided for temporary critical roles.
Funding Insights of AIM
Detailed funding history for AIM
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in AIM
AIM has secured backing from 1 investor. Prominent investors backing the company include Blue Matter Consulting.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of consulting services focused for clinical drug development
|
Locked | Locked | Locked |
Investor details for AIM
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AIM
Investment portfolio details for AIM
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AIM
Detailed financials for AIM
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aim Comparisons
Peer comparison for AIM
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AIM
AIM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as McKesson, Resilience, Entero Healthcare, BioAscent and Zhejiang Mingdu Zhikong Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Products and services are provided in the healthcare industry.
|
|
| Locked | Locked | Locked |
Supply chain services for biopharma sector are provided.
|
|
| Locked | Locked | Locked |
India's leading healthcare products distribution platform
|
|
| Locked | Locked | Locked |
Compound management solutions are offered for drug discovery processes.
|
|
| Locked | Locked | Locked |
AI-based logistics services are provided in Hangzhou, China.
|
|
| Locked | Locked | Locked |
Supply chain solution services for isotope production are provided.
|
Detailed competitors of AIM
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aim
Complete news archive for AIM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AIM
AIM was founded in 2009.
AIM is headquartered in Voorburg, Netherlands. It is registered at Voorburg, South Holland, Netherlands.
AIM is dedicated to providing specialized supply chain consultancy and interim professional solutions for life science companies, including pharmaceutical, biotech, and medical device sectors. Services are offered across strategy, design, implementation, and maintenance support. Clients are served throughout Europe and North America, with expertise in biotech products, vaccines, and diagnostics. Comprehensive support is provided to start-ups and established companies for successful market launches.
AIM's top competitors include Entero Healthcare, McKesson and Resilience.
AIM offers Supply Chain Development, Consulting, Maintenance Support, and Interim Professionals.
AIM has 1 investor. Key investors include Blue Matter Consulting.